300636 同和藥業
按盤價 
10.740 +0.490 (+4.780%)
10.740 +0.490 (+4.780%) | 2024/03 - 三個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 1.937 | 5.977 | 9.119 | 9.518 | 9.200 |
| 總資產報酬率 ROA (%) | 1.318 | 3.868 | 4.833 | 4.808 | 5.642 |
| 投入資產回報率 ROIC (%) | 1.357 | 4.083 | 5.259 | 5.116 | 5.974 | 邊際利潤分析 |
| 銷售毛利率 (%) | 36.667 | 33.301 | 32.428 | 30.206 | 34.944 |
| 營業利潤率 (%) | 23.749 | 15.542 | 14.770 | 14.919 | 17.971 |
| 息稅前利潤/營業總收入 (%) | 21.020 | 14.277 | 15.812 | 15.487 | 20.241 |
| 淨利潤/營業總收入 (%) | 21.100 | 14.676 | 13.983 | 13.700 | 16.088 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 113.944 | 108.657 | 104.621 | 105.109 | 94.981 |
| 價值變動淨收益/利潤總額(%) | 0.000 | 0.505 | -1.139 | 0.312 | 0.087 |
| 營業外收支淨額/利潤總額(%) | -0.136 | 0.238 | -0.172 | 0.000 | -0.243 | 償債能力分析 |
| 流動比率 (X) | 1.911 | 1.706 | 1.318 | 1.784 | 2.577 |
| 速動比率 (X) | 1.176 | 0.960 | 0.453 | 0.749 | 1.278 |
| 資產負債率 (%) | 33.013 | 30.887 | 41.578 | 53.422 | 0.444 |
| 帶息債務/全部投入資本 (%) | 29.807 | 27.165 | 34.571 | 47.163 | 40.485 |
| 股東權益/帶息債務 (%) | 230.589 | 263.003 | 183.985 | 107.399 | 142.223 |
| 股東權益/負債合計 (%) | 202.913 | 223.766 | 140.512 | 87.188 | 125.390 |
| 利息保障倍數 (X) | -7.794 | -10.970 | 14.812 | 27.264 | 8.750 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 41.306 | 39.533 | 36.874 | 24.079 | 36.723 |
| 存貨周轉天數 (天) | 350.286 | 381.473 | 322.210 | 308.733 | 365.721 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 30/04/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
